Market Cap 3.49B
Revenue (ttm) 75.13M
Net Income (ttm) -146.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -194.88%
Debt to Equity Ratio 0.00
Volume 8,189,500
Avg Vol 7,983,604
Day's Range N/A - N/A
Shares Out 306.61M
Stochastic %K 93%
Beta 1.20
Analysts Strong Sell
Price Target $16.12

Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a researc...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 559 9005
Address:
150 W 4th Avenue, Vancouver, Canada
UncleTomFlorida
UncleTomFlorida Aug. 18 at 9:57 PM
$ABCL https://d18rn0p25nwr6d.cloudfront.net/CIK-0001703057/9661d222-ebae-4f3d-a3d2-648c2260bdd4.pdf
0 · Reply
Plan2TradeTrade2Plan
Plan2TradeTrade2Plan Aug. 18 at 9:14 PM
$ABCL another large insider buy. 2 questions: 1. Why didn’t they buy under $5 2. I thought all the news was out, until phase 3 results. Why do insiders, 3 so far, feel that the company’s shares are still cheap to buy now?
3 · Reply
desiguy
desiguy Aug. 18 at 9:06 PM
$ABCL jump to $12.25 by tonight?
0 · Reply
DeMampCamp
DeMampCamp Aug. 18 at 8:38 PM
$ABCL I can only imagine how many fake longs and short timers have sold on the bear traps the last couple of days just to see the share price recover, MMs are absorbing all the profit taking which bodes well for our next leg up! Cheers all!
1 · Reply
SwingTrades1
SwingTrades1 Aug. 18 at 8:25 PM
$ABCL And roughly half the volume was short, while buyers just kept scooping up the supply without much concern. With short availability dropping from 8.5 million to 4.9 million during an 8-million-share session and ABCL barely moving from $11.20 to $11.12 despite the market reversal. That's some serious absorption. I hope the shorts can sleep tonight with only 3.5 million shares still showing as available to short
0 · Reply
Stocktradesmoon
Stocktradesmoon Aug. 18 at 7:46 PM
$ABCL @TradeWinner Look 👀 LEVEL II. Incredible buying by institutions, insiders, and Retail. With the Short interest being as high as it is WE DEFINITELY are going MUCH HIGHER!! When we get PASS $11.38 we got to $20 FOR SURE. Expecting $13-$15 this week! We are going to START JUMPING WHOLE $1 dollars. JUST WATCH.
0 · Reply
TradeWinner
TradeWinner Aug. 18 at 7:39 PM
$ABCL sure has been strong. Guessing higher in the near future. And much higher long term.
1 · Reply
Stocktradesmoon
Stocktradesmoon Aug. 18 at 7:33 PM
$ABCL NOTHING GOING to STOP this 🚂 IT WANT’s $12’ssss
0 · Reply
Stocktradesmoon
Stocktradesmoon Aug. 18 at 7:12 PM
$ABCL WE ABOUT to SHOOT UP RIGHT to $11.60’s!!! 👀
2 · Reply
Stocktradesmoon
Stocktradesmoon Aug. 18 at 7:03 PM
$ABCL WATCH THE ORDERS!! Incredible buys by institutions, insiders, and Retail. With SHORT interest as HIGH as it is we are GOING to START JUMPING and MOVING in $$ WHOLE DOLLARS not Cents anymore! With several hours of CONSOLIDATION this morning and BUYING I EXPECT we CLOSE NEAR $12 or ABOUT!! POWER HOUR
0 · Reply
Latest News on ABCL
AbCellera announces $200M common stock, warrants offering

2026-08-11T20:05:47.000Z - 7 days ago

AbCellera announces $200M common stock, warrants offering


AbCellera price target raised to $30 from $12 at Truist

2026-08-11T13:35:37.000Z - 7 days ago

AbCellera price target raised to $30 from $12 at Truist


AbCellera Biologics Slides: Corporate presentation

Aug 10, 2026, 8:00 AM EDT - 8 days ago

AbCellera Biologics Slides: Corporate presentation


AbCellera Biologics Transcript: Study result

Aug 10, 2026, 7:30 AM EDT - 8 days ago

AbCellera Biologics Transcript: Study result


AbCellera Biologics Press release: Study result

Aug 10, 2026, 7:30 AM EDT - 8 days ago

AbCellera Biologics Press release: Study result


AbCellera Biologics Slides: Study result

Aug 10, 2026, 7:30 AM EDT - 8 days ago

AbCellera Biologics Slides: Study result


AbCellera price target raised to $9 from $8 at Stifel

2026-08-06T12:20:50.000Z - 12 days ago

AbCellera price target raised to $9 from $8 at Stifel


AbCellera Biologics Earnings Call Transcript: Q2 2026

Aug 5, 2026, 5:00 PM EDT - 13 days ago

AbCellera Biologics Earnings Call Transcript: Q2 2026


AbCellera Biologics Slides: Q2 2026

Aug 5, 2026, 5:00 PM EDT - 13 days ago

AbCellera Biologics Slides: Q2 2026


AbCellera Biologics Earnings release: Q2 2026

Aug 5, 2026, 5:00 PM EDT - 13 days ago

AbCellera Biologics Earnings release: Q2 2026


AbCellera Biologics Quarterly report: Q2 2026

Aug 5, 2026, 5:00 PM EDT - 13 days ago

AbCellera Biologics Quarterly report: Q2 2026


AbCellera Reports Q2 2026 Business Results

Aug 5, 2026, 4:05 PM EDT - 13 days ago

AbCellera Reports Q2 2026 Business Results


AbCellera upgraded to Buy from Hold at Benchmark

2026-07-07T10:35:14.000Z - 6 weeks ago

AbCellera upgraded to Buy from Hold at Benchmark

JAZZ


AbCellera apponts Lynn Seely to board of directors

2026-07-06T13:15:29.000Z - 6 weeks ago

AbCellera apponts Lynn Seely to board of directors

LYEL


AbCellera Appoints Dr. Lynn Seely to its Board of Directors

Jul 6, 2026, 9:00 AM EDT - 6 weeks ago

AbCellera Appoints Dr. Lynn Seely to its Board of Directors


AbCellera appoints Victor Sandor to board of directors

2026-06-05T13:05:56.000Z - 2 months ago

AbCellera appoints Victor Sandor to board of directors


AbCellera Appoints Dr. Victor Sandor to its Board of Directors

Jun 5, 2026, 9:00 AM EDT - 2 months ago

AbCellera Appoints Dr. Victor Sandor to its Board of Directors


AbCellera Biologics Earnings Call Transcript: Q1 2026

May 11, 2026, 5:00 PM EDT - 3 months ago

AbCellera Biologics Earnings Call Transcript: Q1 2026


AbCellera Biologics Earnings release: Q1 2026

May 11, 2026, 5:00 PM EDT - 3 months ago

AbCellera Biologics Earnings release: Q1 2026


AbCellera Biologics Quarterly report: Q1 2026

May 11, 2026, 5:00 PM EDT - 3 months ago

AbCellera Biologics Quarterly report: Q1 2026


AbCellera Biologics Slides: Q1 2026

May 11, 2026, 5:00 PM EDT - 3 months ago

AbCellera Biologics Slides: Q1 2026


AbCellera Biologics Slides: Corporate presentation

May 1, 2026, 8:00 AM EDT - 3 months ago

AbCellera Biologics Slides: Corporate presentation


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 3 months ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 3 months ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera Biologics Earnings Call Transcript: Q4 2025

Feb 24, 2026, 5:00 PM EST - 6 months ago

AbCellera Biologics Earnings Call Transcript: Q4 2025


AbCellera Biologics Annual report: Q4 2025

Feb 24, 2026, 5:00 PM EST - 6 months ago

AbCellera Biologics Annual report: Q4 2025


AbCellera Biologics Earnings release: Q4 2025

Feb 24, 2026, 5:00 PM EST - 6 months ago

AbCellera Biologics Earnings release: Q4 2025


AbCellera Biologics Slides: Q4 2025

Feb 24, 2026, 5:00 PM EST - 6 months ago

AbCellera Biologics Slides: Q4 2025


AbCellera Reports Full Year 2025 Business Results

Feb 24, 2026, 4:05 PM EST - 6 months ago

AbCellera Reports Full Year 2025 Business Results


AbCellera Biologics Slides: Corporate presentation

Jan 14, 2026, 7:00 AM EST - 7 months ago

AbCellera Biologics Slides: Corporate presentation


AbCellera Appoints Dr. Stephen Quake to its Board of Directors

Nov 10, 2025, 9:00 AM EST - 10 months ago

AbCellera Appoints Dr. Stephen Quake to its Board of Directors


AbCellera Biologics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 5:00 PM EST - 10 months ago

AbCellera Biologics Earnings Call Transcript: Q3 2025


AbCellera Biologics Quarterly report: Q3 2025

Nov 6, 2025, 5:00 PM EST - 10 months ago

AbCellera Biologics Quarterly report: Q3 2025


AbCellera Biologics Earnings release: Q3 2025

Nov 6, 2025, 5:00 PM EST - 10 months ago

AbCellera Biologics Earnings release: Q3 2025


AbCellera Biologics Slides: Q3 2025

Nov 6, 2025, 5:00 PM EST - 10 months ago

AbCellera Biologics Slides: Q3 2025


AbCellera Reports Q3 2025 Business Results

Nov 6, 2025, 4:05 PM EST - 10 months ago

AbCellera Reports Q3 2025 Business Results


AbCellera Biologics Earnings Call Transcript: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q2 2025


AbCellera Biologics Quarterly report: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q2 2025


AbCellera Biologics Earnings release: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q2 2025


AbCellera Biologics Slides: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q2 2025


AbCellera Biologics Slides: Corporate Presentation

Aug 1, 2025, 7:00 AM EDT - 1 year ago

AbCellera Biologics Slides: Corporate Presentation


AbCellera Biologics Earnings Call Transcript: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q1 2025


AbCellera Biologics Earnings release: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q1 2025


AbCellera Biologics Quarterly report: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q1 2025


AbCellera Biologics Slides: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q1 2025


AbCellera Reports Q1 2025 Business Results

May 8, 2025, 4:05 PM EDT - 1 year ago

AbCellera Reports Q1 2025 Business Results


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Earnings Call Transcript: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q4 2024


AbCellera Biologics Earnings release: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q4 2024


AbCellera Biologics Annual report: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Annual report: Q4 2024


AbCellera Biologics Slides: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q4 2024


AbCellera Reports Full Year 2024 Business Results

Feb 27, 2025, 4:05 PM EST - 1 year ago

AbCellera Reports Full Year 2024 Business Results


AbCellera Biologics Slides: FY 2025

Jan 15, 2025, 7:30 PM EST - 1 year ago

AbCellera Biologics Slides: FY 2025


AbCellera Biologics Earnings Call Transcript: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q3 2024


AbCellera Biologics Quarterly report: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Quarterly report: Q3 2024


AbCellera Biologics Earnings release: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q3 2024


AbCellera Biologics Slides: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q3 2024


AbCellera Reports Q3 2024 Business Results

Nov 4, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Q3 2024 Business Results


UncleTomFlorida
UncleTomFlorida Aug. 18 at 9:57 PM
$ABCL https://d18rn0p25nwr6d.cloudfront.net/CIK-0001703057/9661d222-ebae-4f3d-a3d2-648c2260bdd4.pdf
0 · Reply
Plan2TradeTrade2Plan
Plan2TradeTrade2Plan Aug. 18 at 9:14 PM
$ABCL another large insider buy. 2 questions: 1. Why didn’t they buy under $5 2. I thought all the news was out, until phase 3 results. Why do insiders, 3 so far, feel that the company’s shares are still cheap to buy now?
3 · Reply
desiguy
desiguy Aug. 18 at 9:06 PM
$ABCL jump to $12.25 by tonight?
0 · Reply
DeMampCamp
DeMampCamp Aug. 18 at 8:38 PM
$ABCL I can only imagine how many fake longs and short timers have sold on the bear traps the last couple of days just to see the share price recover, MMs are absorbing all the profit taking which bodes well for our next leg up! Cheers all!
1 · Reply
SwingTrades1
SwingTrades1 Aug. 18 at 8:25 PM
$ABCL And roughly half the volume was short, while buyers just kept scooping up the supply without much concern. With short availability dropping from 8.5 million to 4.9 million during an 8-million-share session and ABCL barely moving from $11.20 to $11.12 despite the market reversal. That's some serious absorption. I hope the shorts can sleep tonight with only 3.5 million shares still showing as available to short
0 · Reply
Stocktradesmoon
Stocktradesmoon Aug. 18 at 7:46 PM
$ABCL @TradeWinner Look 👀 LEVEL II. Incredible buying by institutions, insiders, and Retail. With the Short interest being as high as it is WE DEFINITELY are going MUCH HIGHER!! When we get PASS $11.38 we got to $20 FOR SURE. Expecting $13-$15 this week! We are going to START JUMPING WHOLE $1 dollars. JUST WATCH.
0 · Reply
TradeWinner
TradeWinner Aug. 18 at 7:39 PM
$ABCL sure has been strong. Guessing higher in the near future. And much higher long term.
1 · Reply
Stocktradesmoon
Stocktradesmoon Aug. 18 at 7:33 PM
$ABCL NOTHING GOING to STOP this 🚂 IT WANT’s $12’ssss
0 · Reply
Stocktradesmoon
Stocktradesmoon Aug. 18 at 7:12 PM
$ABCL WE ABOUT to SHOOT UP RIGHT to $11.60’s!!! 👀
2 · Reply
Stocktradesmoon
Stocktradesmoon Aug. 18 at 7:03 PM
$ABCL WATCH THE ORDERS!! Incredible buys by institutions, insiders, and Retail. With SHORT interest as HIGH as it is we are GOING to START JUMPING and MOVING in $$ WHOLE DOLLARS not Cents anymore! With several hours of CONSOLIDATION this morning and BUYING I EXPECT we CLOSE NEAR $12 or ABOUT!! POWER HOUR
0 · Reply
Bullock3000
Bullock3000 Aug. 18 at 7:00 PM
$ABCL Bull Trap at $11.22.
0 · Reply
Bullock3000
Bullock3000 Aug. 18 at 6:59 PM
$ABCL Michael R. Hayen's (LEAD DIRECTOR) spouse owns 1.3M shares inside her consulting company called "Genworks 2", she owns 118K shares under her own name. Total = 1.438M shares. This means s(he) can sell covered calls for income, sell the stock, buy puts etc... NOTHING SHADY ...LoL.
2 · Reply
psyxopathis
psyxopathis Aug. 18 at 6:59 PM
1 · Reply
psyxopathis
psyxopathis Aug. 18 at 6:56 PM
$ABCL See you in a few months. Long and strong 💪
0 · Reply
CrestFresh
CrestFresh Aug. 18 at 6:52 PM
0 · Reply
Stocktradesmoon
Stocktradesmoon Aug. 18 at 6:51 PM
$ABCL EVERYBODY GET ON BOARD 🚂 HERE WE GO!! We been CONSOLIDATING ALL MORNING NOW WE KNOCK ✊🏻 OUT $12’ssssss
0 · Reply
Cello69
Cello69 Aug. 18 at 6:48 PM
$ABCL WOW
0 · Reply
Stocktradesmoon
Stocktradesmoon Aug. 18 at 6:42 PM
$ABCL $ABCL Analyst price target Re-ratings: - Truist - $30 - Jones - $25 - Cantor - $20 - BMO - $15
0 · Reply
Stocktradesmoon
Stocktradesmoon Aug. 18 at 6:39 PM
$ABCL $ABCL I’ve got a strong feeling Lilly will be on the phone over the next few days. Big partnership for 635 incoming.. Full fund of phase 3 + a large upfront payment ($1B?) + 50% royalties? $ABCL
1 · Reply
Bullock3000
Bullock3000 Aug. 18 at 6:38 PM
$ABCL ZERO PRODUCTS
1 · Reply
Stocktradesmoon
Stocktradesmoon Aug. 18 at 6:37 PM
$ABCL $ABCL Bmo and Truist out today with them-2month PT’s.
0 · Reply
hagarone
hagarone Aug. 18 at 6:37 PM
$ABCL You said “zero products”. That is incorrect. It was revoked because it was ineffective against Covid variants. At least try to post facts.
1 · Reply